LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Elite Athletes Protected Against Diabetes
Large Joints and Extremities

Elite Athletes Protected Against Diabetes

November 22, 2013 2 min read Premium comments

Advertisement

Elite Athletes Protected Against Diabetes
Andres Silva / Source: Wikimedia Commons and N.varcasia
Secondary

A study of almost 400 former elite male athletes shows that former status as an elite athlete reduces the risk of developing type 2 diabetes in later life by 28%. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes (EASD), and is by Dr. Merja Laine, University of Helsinki, Helsinki, Finland, and colleagues.

The study of Finnish male athletes follows-up on work that began in 1985, when a questionnaire was sent to 1, 518 former athletes and 1, 010 controls, and further questionnaires were sent out in1995 and 2001. In 2008, an invitation to participate in a clinical study was sent to all former athletes who were still alive (747, of whom 392 participated) and controls (436, of whom 207 participated) and had answered at least one of the previous questionnaires. The clinical study included a physical examination, laboratory tests and questionnaires.

The former athletes were divided into three groups based on their active career sport: endurance, mixed and power sports. Participants without a history of diabetes underwent an oral glucose tolerance test (75g of glucose delivered over 2 hours). Current volume of leisure-time physical activity (LTPA) was determined by self-reported questionnaires and expressed in metabolic equivalent hours. Data on reimbursable diabetes medication from participants and non-participants were obtained from a central Finnish register.

The researchers found that being a former elite athlete reduced the risk of developing type 2 diabetes by a statistically significant 28%. However, this reduction varied among the different sports categories: the risk reduction was 61% for those who had had careers in endurance sports (a statistically significant finding) while for mixed sports the reduction was 21% and power sports was 23% (both not statistically significant).

The risk of type 2 diabetes decreased with increased LTPA volume, by 2% per 1 MET-h per week. The former elite athletes also had a 42% lower risk of impaired glucose tolerance (IGT), a precursor state to full blown diabetes. The authors said in the news release, “With ageing, the former athletes maintained their physically active lifestyle better than the controls.” They conclude: “A former career as an elite athlete protected from both type 2 diabetes and IGT in later life. In addition, the volume of current leisure-time physical activity was inversely associated with the prevalence of type 2 diabetes.”

Dr. Laine told OTW, “The former athletes were divided into three groups. The division was made according to the type training needed to achieve optimal results. Endurance sports (long and middle distance running, cross country skiing), mixed sports (soccer, ice hockey, basketball, track and field: jumpers, sprinters, hurdlers, decathletes) and power sports (boxing, wrestling, weight lifting, track and field throwers).”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy